A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes
Clinical trial NCT06845943 · SUSPENDED
Trial details
- NCT number
- NCT06845943
- Sponsor
- Helicore Biopharma, Inc.
- Status
- SUSPENDED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-04
- Primary completion
- 2025-10-22
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.